<?xml version="1.1" encoding="UTF-8" standalone="yes"?><xml><head><creation_date>D:20050811171601+02'00'</creation_date><modification_date>D:20060322180545+01'00'</modification_date><initial_authorization>False</initial_authorization><pdf_file>EU-1-00-168_h_dec_8.pdf</pdf_file></head><body><section><header>en  
   en</header></section><section><header>en</header><p>commission of the european communities</p><p>brussels, 09-viii-2005 c(2005) 3157 
 not for publication</p></section><section><header>commission decision of 09-viii-2005 
 withdrawing, at the holder&apos;s request, the marketing authorisation granted by 
 decision c(2001)286 for &quot;tenecteplase boehringer ingelheim pharma gmbh &amp; co. 
 kg - tenecteplase&quot;, a medicinal product for human use</header><p>only the german text is authentic</p></section><section><header>en  
   en</header></section><section><header>commission decision of 09-viii-2005 
 withdrawing, at the holder&apos;s request, the marketing authorisation granted by 
 decision c(2001)286 for &quot;tenecteplase boehringer ingelheim pharma gmbh &amp; co. 
 kg - tenecteplase&quot;, a medicinal product for human use 
 (text with eea relevance)</header><p>the commission of the european communities, having regard to the treaty establishing the european community,</p><p>
 having regard to council regulation (eec) no 2309/93 of 22 july 1993 laying down 
 community procedures for the authorisation and supervision of medicinal products for 
 human and veterinary use and establishing a european agency for the evaluation of 
 medicinal products
 1, having regard to the application submitted by boehringer ingelheim international gmbh 
 on 28 june 2005 with a view to the withdrawal of the marketing authorisation for the 
 medicinal product &quot;tenecteplase boehringer ingelheim pharma gmbh &amp; co. kg - 
 tenecteplase&quot; 
 whereas: 
 (1)</p><p>the placing on the market of the medicinal product &quot;tenecteplase boehringer 
 ingelheim pharma gmbh &amp; co. kg - tenecteplase&quot;, which is entered in the 
 community register of medicinal products under the numbers eu/1/00/168/001-
 006 was authorised by commission decision c(2001)286 of 23 february 2001. 
 (2)</p><p>following the holder&apos;s request, that authorisation should be withdrawn, 
 has adopted this decision: 
 article 1 at the holder&apos;s request, the marketing authorisation granted by decision c(2001)286 of 23 february 2001 for the medicinal product &quot;tenecteplase boehringer ingelheim pharma 
 gmbh &amp; co. kg - tenecteplase&quot; is withdrawn.</p><p>
 1 oj l 214, 24.8.1993, p. 1. regulation as last amended by [regulation (ec) no 1647/2003 (oj l 245, 29.9.2003, p. 19)].</p></section><section><header>en  
   en</header><p>article 2 this decision is addressed to boehringer ingelheim international gmbh, binger strasse 173, d-55216 ingelheim am rhein, deutschland. 
 done at brussels, 09-viii-2005 
 for the commission g√ºnter verheugen 
 member of the commission</p></section></body></xml>